ArrowMark Partners key facts
- ArrowMark Partners is a asset manager based in Denver, Colorado with 14 tracked portfolio companies.
- Notable positions include Freenome, Formation Bio, Skyryse.
- PrivateMarketView records 1 deal participation by ArrowMark Partners.
- ArrowMark Partners’s most recent recorded investment was in Oct 2021.
- The team roster lists 20 people.
About ArrowMark Partners
Founded in 2007, ArrowMark Partners is an asset manager headquartered in Denver, Colorado. The firm seeks to make investments in alternative credit and growth equity asset classes. The firm focuses on public and private credit & equity, leveraged loans, and middle-market commercial real estate finance. This firm is a Registered Investment Adviser.
Investment activity
ArrowMark Partners has no recorded round in the last two years; its 1 recorded round dates from 2021 to Oct 2021. Most recently: Skyryse (Series B, Oct 2021).
ArrowMark Partners portfolio at a glance
14 portfolio companies are on record for ArrowMark Partners, including Freenome, Formation Bio and Skyryse. The book leans Biotechnology (2), Drug Discovery (2) and Aerospace and Defense (1).
9 of the 14 carry a recorded valuation.
ArrowMark Partners team
20 people are on record at ArrowMark Partners: 8 partners, 4 principals, 1 managing partner, 1 analyst and 6 others. Senior names include Peter Albro (Managing Director), Brian Schaub (Partner) and Chad Meade (Partner). 20 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
ArrowMark Partners at the SEC
Form ADV · 2026-03 · CRD 307161- Regulatory AUM
- —
- Private fund assets
- —
- Private funds
- —
- Staff
- 5
- Registered office
- DENVER, CO
- SEC status
- Approved
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as ARROWMARK ASSET MANAGEMENT, LLC).
- ·The top 10 names in the book — of 14 recorded positions
- ·Watchlist + alerts for ArrowMark Partners's activity
Portfolio
14 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ |
| Formation Bio | Drug Discovery | ▮ | ▮ | ▮ |
| Skyryse | Aerospace and Defense | ▮ | ▮ | ▮ |
+ 11 more companies · all 14, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
ArrowMark Partners recent deals
1 recordedMembership and data by Private Market View
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about ArrowMark Partners
- What companies does ArrowMark Partners invest in?
- ArrowMark Partners has 14 recorded portfolio companies, including Freenome, Formation Bio, Skyryse.
- What is ArrowMark Partners's AUM?
- ArrowMark Partners manages approximately $18.5B in assets.
- Is ArrowMark Partners actively investing?
- ArrowMark Partners's most recent recorded investment was in Oct 2021.